NANCY POLASHUK: Open Payments
NPI 1114449451 · SPRING GROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 14 payments from 8 companies in 2025. Trend: 2023 $1,635 · 2024 $221 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $88 |
| ABBVIE INC. | 3 | $71 |
| Lilly USA, LLC | 2 | $36 |
| Organon LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: VRAYLAR, Ozempic, Rybelsus, MOUNJARO, NEXPLANON, BREZTRI, ELIQUIS, QULIPTA.
Industry payments across PA — which companies pay providers there.
